Effects of COVID-19 on Pediatric Cancer Care: A Multicenter Study of 11 Middle Eastern Countries.


Journal

Journal of pediatric hematology/oncology
ISSN: 1536-3678
Titre abrégé: J Pediatr Hematol Oncol
Pays: United States
ID NLM: 9505928

Informations de publication

Date de publication:
01 01 2023
Historique:
received: 16 01 2022
accepted: 15 08 2022
pubmed: 12 10 2022
medline: 7 1 2023
entrez: 11 10 2022
Statut: ppublish

Résumé

During the COVID-19 pandemic, major challenges are facing pediatric cancer centers regarding access to cancer centers, continuity of the anti-cancer therapy, hospital admission, and infection protection precautions. Pediatric oncologists actively treating children with cancer from 29 cancer centers at 11 countries were asked to answer a survey from May 2020 to August 2020 either directly or through the internet. COVID-19 pandemic affected the access to pediatric cancer care in the form of difficulty in reaching the center in 22 (75.9%) centers and affection of patients' flow in 21 (72.4%) centers. Health care professionals (HCP) were infected with COVID-19 in 20 (69%) surveyed centers. Eighteen centers (62%) modified the treatment guidelines. Care of follow-up patients was provided in-hospital in 8(27.6%) centers, through telemedicine in 10 (34.5%) centers, and just delayed in 11 (38%) centers. Pediatric oncologists had different expectations about the future effects of COVID-19 on pediatric cancer care. Seventy-six percent of pediatric oncologists think the COVID-19 pandemic will increase the use of telemedicine. Fifty-five percent of pediatric oncologists think if the COVID-19 pandemic persists, we will need to change chemotherapy protocols to less myelosuppressive ones. Collaborative studies are required to prioritize pediatric cancer management during COVID-19 era.

Identifiants

pubmed: 36219708
doi: 10.1097/MPH.0000000000002564
pii: 00043426-202301000-00028
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e87-e91

Informations de copyright

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

The authors declare no conflicts of interest.

Références

Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270–273.
Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–733.
World Health Organization (WHO). Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). Available at: https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov) ; https://web.archive.org/web/20200131005904/https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov) . Accessed April 19, 2020.
World Health Organization (WHO) (Press release). WHO Director-General’s opening remarks at the media briefing on COVID-19. Available at: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 ; ( https://web.archive.org/web/20200311212521/https://www.who.int/dg/speeches/detail/who-director-general-sopening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 ). Accessed April 19,2020.
Zhang L, Zhu F, Xie L, et al. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Ann Oncol. 2020;31:894–901.
CDC COVID data tracker. Demographic trends of COVID-19 cases and deaths in the US reported to the CDC. https://www.cdc.gov/covid-data-tracker/index.html#demographics . Accessed October 27, 2020.
Ogimi C, Englund JA, Bradford MC, et al. Characteristics and outcomes of coronavirus infection in children: the role of viral factors and an immunocompromised state. J Pediatr Infect Dis Soc. 2019;8:21–28.
Nada hamadeh, Catherine van rompaey and Eric metreau. New World Bank country classifications by income level: 2021-2022 [World Bank web site]. July 1, 2021. Available at: https://blogs.worldbank.org/opendata/new-world-bank-country-classifications-income-level-2021-2022 . Accessed April 7, 2022.
Steliarova-Foucher E, Colombet M, Ries LA, et al. International incidence of childhood cancer, 2001–10: a population-based registry study. Lancet Oncol. 2017;18:719–731.
Saletta F, Seng MS, Lau LM. Advances in paediatric cancer treatment. Transl Pediatr. 2014;3:156.
Amicucci M, Mastronuzzi A, Ciaralli I, et al. The management of children with cancer during the COVID-19 pandemic: a rapid review. J Clin Med. 2020;9:3756.
Ganguly S, Bakhshi S. Teleconsultations and shared care in pediatric oncology during COVID-19. Indian J Pediatr. 2021;88:1–2.
Boufkhed S, Harding R, Kutluk T, et al. What is the preparedness and capacity of palliative care services in Middle-Eastern and North African countries to respond to COVID-19? A rapid survey. J Pain Symptom Manage. 2021;61:e13–e50.
Bejjani A, Burt L, Washington C, et al. Using a collaborative, virtual discussion platform to mobilize oncologic expertise for the COVID-19 pandemic. JCO Clin Cancer Inform. 2020;4:794–798.

Auteurs

Mahmoud M Elzembely (MM)

Pediatric Oncology Department, South Egypt Cancer Institute, Assiut University.
Pediatric Oncology Department, Shefa Al-Orman Children Cancer Hospital, Luxor.

Abdulhakim Al Rawas (A)

Pediatric Hematology-Oncology and HSCT, Child Health Department, Sultan Qaboos University Hospital.

Abdulqader Al-Hebshi (A)

Prince Mohammed Bin Abdulaziz Hospital, Ministry of National Guard Health Affairs, Medinah.

Abdulrahman Alhadi (A)

Childhood Leukemia Center, Sana'a Faculty for Medical Science.

Ahmed K Ibrahim (AK)

Public Health Department, faculty of Medicine, Assiut University.

Amal Ahmed Zein (AA)

Nasser Institute Hospital Cancer Centre, Cairo.

Iman Ragab (I)

Hematology Oncology Unit , Ain Shams University Children 's Hospital.

Eman Taryam Alshamsi (ET)

Tawam Hospital, Al Ain, UAE.

Enas Dammag (E)

Faculty of Medicine ,Taiz University.

Fatiha Gachi (F)

Pediatric Oncology Unit, Pierre and Marie Curie Center.

Gamal Hussien Zain (GH)

National Oncology Center at Al wahda Teaching Hospital.

Hadeel Saleh Mohammad (HS)

NBK Children's Hospital, Kuwait.

Hisham Haddad (H)

National Oncology Center, Hadhramout Alwadi, Seiyun.

Houda Boudiaf (H)

Department of Pediatric Oncology, Mustapha Hospital Algiers, Algeria.

Ibrahim Alharbi (I)

King Fahad Armed Forces Hospital, Saudi Arabia.

Iyad Sultan (I)

King Hussein Cancer Center.

Khadra Hasan Salami (KH)

Augusta Victoria hospital/Jerusalem, Palestine.

Mohamed S Bayoumy (MS)

King Faisal Specialist Hospital, Jeddah.

Naima Ali Al-Mulla (NA)

Sidra Medicine, Hamad Medical Corporation, Doha, Qatar.

Nawal Al Mashaikhi (N)

Royal Hospital, Muscat, Oman.

Rami Mohammed Almajali (RM)

Pediatric Department, Faculty of Medicine, Mutah University.

Roula Farah (R)

Department of Pediatrics, Lebanese American University Medical Center-Rizk Hospital, Beirut, Lebanon.

Saad A Al Daama (SA)

King Fahed Specialist Hospital, Dammam.

Salah Ahmad (S)

Sohag Cancer Center, MOH.

Seham M Ragab (SM)

Faculty of Medicine Menoufia University.

Shady H Fadel (SH)

Clinical Oncology Department, Alexandria University.

Soha Ahmed (S)

Clinical Oncology Department, Suez University.

Suleimman Al-Sweedan (S)

Pediatric Oncology, Jordan university of Science and Technology, Irbid, Jordan.

Suzy Abdelmabood (S)

Pediatric Hematology Oncology and BMT Unit, Faculty of Medicine, Mansoura University.

Waleed Khaled Kaleem (WK)

National Oncology Center, Ibn Sina General Hospital, Mukalla, Yemen.

Youssef Madney (Y)

Department of Pediatric Oncology, National Cancer Institute, Cairo University.
Children Cancer Hospital Egypt (CCHE), Pediatric Oncology Department, Egypt.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH